Taiko, an Ethereum layer 2 network, has increased the share of the base fee allocated to block proposers to 100%, effective from October 19. This change removes a cost barrier for proposers who cover the base fee on behalf of users, allowing them to receive the full fee amount. The adjustment applies only to the layer 2 base fee and does not make transactions free or gasless for users. Additionally, the update includes new trusted proof-verification identifiers for raiko2 v0.9.0, discontinuing acceptance of proofs tied to older identifiers.
Taiko's update on block proposer fees provides context for readers interested in blockchain developments. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Oct 21, 2026 00:22 WIB: Out of 50 major cryptocurrencies, 44 rose and 5 fell today. VeChain (VET) gained 4.90% to Rp127 with a nearly balanced order activity of 49% Sell and 51% Buy, while Nano (XNO) rose 4.69% to Rp6.178 with a full 100% Buy order activity, contrasting with Algorand (ALGO) which increased 3.82% to Rp2.039 but saw 62% Sell orders and 38% Buy, indicating differing investor sentiment and hold times ranging from 86 to 148 days on Pluang.
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...
Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...
